Back to Screener

GeneDx Holdings Corp. Warrant (WGSWW)

Price$0.01

Favorite Metrics

Price vs S&P 500 (26W)-100.97%
Price vs S&P 500 (4W)-58.77%

All Metrics

Price vs S&P 500 (YTD)-88.21%
10-Day Avg Trading Volume0.04M
3-Month Avg Trading Volume0.05M
52-Week High$0.20
26-Week Price Return-92.22%
13-Week Price Return-81.43%
3-Month Return Std Dev314.45%
Year-to-Date Return-85.23%
5-Day Price Return-5.41%
Month-to-Date Return-12.50%
Price vs S&P 500 (13W)-84.30%
Beta4.26x
52-Week Low$0.00

Industry Peers — Health Services(14)

SymbolP/E Ratio (Annual)Revenue Growth TTM (YoY)Operating Margin (TTM)ROE (TTM)Price
WGSWWGeneDx Holdings Corp. Warrant
$0.01
PRVAPrivia Health Group, Inc. Common Stock
131.66x22.26%1.61%3.29%$24.08
LFSTLifeStance Health Group, Inc. Common Stock
277.93x-12.76%2.07%0.65%$6.92
WGSGeneDx Holdings Corp. Class A Common Stock
39.97%-3.06%-7.41%$69.71
USPHUS Physical Therapy Inc
28.66x16.33%11.08%8.00%$75.72
INNVInnovAge Holding Corp. Common Stock
13.48%1.01%2.66%$7.95
PNTGThe Pennant Group, Inc. Common Stock
36.33x36.31%5.47%9.31%$29.64
TALKTalkspace, Inc. Common Stock
111.06x22.00%1.38%6.89%$5.18
OMDAOmada Health, Inc. Common Stock
-5.41%-7.10%$14.04
SRTAStrata Critical Medical, Inc. Class A Common Stock
9.61x-3.02%-10.18%16.45%$4.52
DCGODocGo Inc. Common Stock
3.28x-47.74%-56.81%-71.45%$0.68

About

GeneDx Holdings is a genomics company providing diagnostic testing for rare and ultra-rare pediatric genetic disorders through exome and genome sequencing. The company is positioned to capitalize on the expected shift toward genetic testing as a standard diagnostic tool for genetic disease. Its services enable early diagnosis and precision medicine while generating valuable genomic data for clinical discovery and improved patient outcomes.